Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
The role of insulin resistance and beta-cell response in the development of metabolic dysfunction-associated steatotic liver disease in lean individuals.
Journal: Proceedings (Baylor University. Medical Center)
Published: November 10, 2025
Lack of Association of Emotional Distress With Insulin Initiation in the GRADE Randomized Diabetes Comparative Effectiveness Trial.
Journal: The science of diabetes self-management and care
Published: August 02, 2025
Glucose-Lowering Medications, Glycemia, and Cognitive Outcomes: The GRADE Randomized Clinical Trial.
Glucose-Lowering Medications, Glycemia, and Cognitive Outcomes: The GRADE Randomized Clinical Trial.
Journal: JAMA internal medicine
Published: May 19, 2025
Immunogenicity, Efficacy, and Safety of Biosimilar Insulin Glargine (Gan & Lee Glargine) Compared With Originator Insulin Glargine (Lantus) in Patients With Type 1 Diabetes After 26 Weeks Treatment.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Published: February 10, 2024
Impact of Simultaneous Versus Sequential Initiation of Basal Insulin and Glucagon-like Peptide-1 Receptor Agonists on HbA1c in Type 2 Diabetes: A Retrospective Observational Study.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: December 20, 2019
Optimization of Metformin in the GRADE Cohort: Effect on Glycemia and Body Weight.
Journal: Diabetes care
Published: September 03, 2019
Risk of clinically relevant hypoglycaemia in patients with type 2 diabetes self-titrating insulin glargine U-100.
Journal: Diabetes, obesity & metabolism
Published: February 22, 2019
Results of VERTIS SU extension study: safety and efficacy of ertugliflozin treatment over 104 weeks compared to glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin.
Journal: Current medical research and opinion
Published: February 15, 2019
Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 2 diabetes: A randomized, open-label clinical trial.
Journal: Diabetes, obesity & metabolism
Published: March 22, 2018
Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 1 diabetes: A randomized, open-label clinical trial.
Journal: Diabetes, obesity & metabolism
Published: March 22, 2018
Last Updated: 09/26/2026